New Uses for Old Drugs: Neonatal Diabetes and Sulphonylureas

被引：35

作者：

Ashcroft, Frances M. ^{[1
]}

机构：

[1] Univ Oxford, Dept Physiol Anat & Genet, Henry Wellcome Ctr Gene Funct, Oxford OX1 3PT, England

来源：

CELL METABOLISM | 2010年 / 11卷 / 03期

关键词：

K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; ACTIVATING MUTATION; KIR6.2; MUTATIONS; SUBUNIT KIR6.2; DEND SYNDROME; KCNJ11; THERAPY; GENE; EXPRESSION;

D O I：

10.1016/j.cmet.2010.02.004

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：179 / 181

页数：3

共 19 条

[1]

ASHCROFT FM, 2007, AM J PHYSIOL-ENDOC M, V88, pE889

[2] Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic β cells recapitulates neonatal diabetes [J].

Girard, Christophe A. ;

Wunderlich, F. Thomas ;

Shimomura, Kenju ;

Collins, Stephan ;

Kaizik, Stephan ;

Proks, Peter ;

Abdulkader, Fernando ;

Clark, Anne ;

Ball, Vicky ;

Zubcevic, Lejla ;

Bentley, Liz ;

Clark, Rebecca ;

Church, Chris ;

Hugill, Alison ;

Galvanovskis, Juris ;

Cox, Roger ;

Rorsman, Patrik ;

Bruening, Jens C. ;

Ashcroft, Frances M. .

JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (01) :80-90

[3] Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes [J].

Gloyn, AL ;

Pearson, ER ;

Antcliff, JF ;

Proks, P ;

Bruining, GJ ;

Slingerland, AS ;

Howard, N ;

Srinivasan, S ;

Silva, JMCL ;

Molnes, J ;

Edghill, EL ;

Frayling, TM ;

Temple, IK ;

Mackay, D ;

Shield, JPH ;

Sumnik, Z ;

van Rhijn, A ;

Wales, JKH ;

Clark, P ;

Gorman, S ;

Aisenberg, J ;

Ellard, S ;

Njolstad, PR ;

Ashcroft, FM ;

Hattersley, AT .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1838-1849

[4] Sulphonylurea action revisited - the post-cloning era [J].

Gribble, FM ;

Reimann, F .

DIABETOLOGIA, 2003, 46 (07) :875-891

[5] Activating mutations in Kir6.2 and neonatal diabetes - New clinical syndromes, new scientific insights, and new therapy [J].

Hattersley, AT ;

Ashcroft, FM .

DIABETES, 2005, 54 (09) :2503-2513

[6] Targeted overactivity of β cell KATP channels induces profound neonatal diabetes [J].

Koster, JC ;

Marshall, BA ;

Ensor, N ;

Corbett, JA ;

Nichols, CG .

CELL, 2000, 100 (06) :645-654

[7] Tolerance for ATP-insensitive KATP channels in transgenic mice [J].

Koster, JC ;

Knopp, A ;

Flagg, TP ;

Markova, KP ;

Sha, Q ;

Enkvetchakul, D ;

Betsuyaku, T ;

Yamada, KA ;

Nichols, CG .

CIRCULATION RESEARCH, 2001, 89 (11) :1022-1029

[8] The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy [J].

Koster, Joseph C. ;

Cadario, Francesco ;

Peruzzi, Cinzia ;

Colombo, Carlo ;

Nichols, Colin G. ;

Barbetti, Fabrizio .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03) :1054-1061

[9] Kir6.2 mutations causing neonatal diabetes prevent endocytosis of ATP-sensitive potassium channels [J].

Mankouri, Jamel ;

Taneja, Tarvinder K. ;

Smith, Andrew J. ;

Ponnambalam, Sreenivasan ;

Sivaprasadarao, Asipu .

EMBO JOURNAL, 2006, 25 (17) :4142-4151

[10] Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11 [J].

Mlynarski, Woj Ciech ;

Tarasov, Andrei I. ;

Gach, Agnieszka ;

Girard, Christophe A. ;

Pietrzak, Wona ;

Zubcevic, Lejla ;

Kusmierek, Jacek ;

Klupa, Tornasz ;

Malecki, Maciej T. ;

Ashcroft, Frances M. .

NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (11) :640-645

← 1 2 →